"artigo cient\u00EDfico"@pt . . . "2009-07-14T00:00:00Z"^^ . "article scientifique"@fr . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@en . "vedeck\u00FD \u010Dl\u00E1nok"@sk . . . . . "wissenschaftlicher Artikel"@de . . . . . "F Graziano" . "v\u011Bdeck\u00FD \u010Dl\u00E1nek"@cs . "articolo scientifico"@it . . . . . . . . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@ast . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@nl . "I Stasi" . . . "K Bencardino" . . . "wetenschappelijk artikel"@nl . "M Magnani" . . . "4" . . . . . . . . "scientific article published on 14 July 2009"@en . . "26671604" . . . . . "19603018" . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2009"@ast . . "G Masi" . . . . . . . . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@en . "I Floriani" . . . . . . "bilimsel makale"@tr . . . . . "101" . . . . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@nl . . "N Galluccio" . . "715-721" . . . . . . . . . . . . . . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@ast . "article cient\u00EDfic"@ca . "videnskabelig artikel"@da . . . . . . . . "vetenskaplig artikel"@sv . "V Catalano" . . "E Canestrari" . . "10.1038/SJ.BJC.6605177" . . . . . . . . . . . . "2736831" . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@ast . . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer"@en . "\u043D\u0430\u0443\u0447\u043D\u0438 \u0447\u043B\u0430\u043D\u0430\u043A"@sr . . . . . . . . . . . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@en . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u043B\u0438\u043F\u043D\u0456 2009"@uk . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 \u0646\u0634\u0631\u062A \u0641\u064A 14 \u064A\u0648\u0644\u064A\u0648 2009"@ar . . . "KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer."@nl .